Internal Medicine Doctors in La, CA Accepting Medicare
5 Internal Medicine doctors found. Showing 1 - 5
 Dr. Frank Koji Mori, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 6801 Park Terrace, 130, La, CA 90045 Phone: 310-649-7222 |
Mr. Felipe L Chu, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 711 N Alvarado St, Ste 101, La, CA 90026 Phone: 213-484-0404 Fax: 213-484-4408 |
 Dr. Eve Louise Makoff, MD Internal Medicine - Hospice and Palliative Medicine Medicare: Medicare Enrolled Practice Location: 8700 Beverly Blvd, La, CA 90048 Phone: 310-248-8076 |
Ralph Terry Potkin, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1125 S Beverly Dr, #406, La, CA 90035 Phone: 310-551-1178 Fax: 310-551-2047 |
Dr. Allan A Orenstein, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 6801 Park Terrace, 130, La, CA 90045 Phone: 310-649-7222 |
News Archive
Nektar presents data of NKTR-181 mu-opioid analgesic candidate at Pain 2010 Symposium
Nektar Therapeutics presented promising data today from preclinical studies of NKTR-181, a next-generation mu-opioid analgesic candidate with a novel molecular design. NKTR-181 is being developed to effectively treat pain while addressing the abuse liability and serious side effects associated with traditional opioid therapies.
NIH awards $2 million grant to test effectiveness of nonmedication ADHD treatments
Florida State University researchers are seeing promising results from "video games" they created as a potential new option to treat Attention-Deficit/Hyperactivity Disorder without medication.
California's highest covid infection rates shift to rural counties
Most of us are familiar with the good news: In recent weeks, rates of covid-19 infection and death have plummeted in California, falling to levels not seen since the early days of the pandemic.
Peptimmune granted US patent for PI-2301 peptide copolymer in treatment of multiple sclerosis
Peptimmune, Inc. a privately held biotechnology company, announced today the grant of US Patent Number 7,655,221 (the '221 patent) which protects the target product profile for its PI-2301 peptide copolymer for the treatment of multiple sclerosis, and other autoimmune diseases.
› Verified 3 days ago
Internal Medicine
Psychiatry & Neurology
Family Medicine
Hematology & Oncology
Anesthesiology
Pediatrics
Surgery